Global Kidney Transplant Market Size, Share, By Donor Type (Living Donor and Deceased Donor), By Type of Transplant (Preemptive Kidney Transplant, Non-Preemptive Kidney Transplant, Combined Kidney-Pancreas Transplant, Re-transplantation, and Others), By End User (Hospitals, Public/Teaching Hospitals, Private Transplant Centers, Transplant Clinics, and Dialysis Centers), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Global Kidney Transplant Market Size Insights Forecasts to 2035

• The Global Kidney Transplant Market Size Was Estimated at USD 8.64 Billion in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.27% from 2025 to 2035
• The Worldwide Kidney Transplant Market Size is Expected to Reach USD 18.70 Billion by 2035
• Asia Pacific is expected to Grow the fastest during the forecast period.

According to a Research Report Published by Spherical Insights, The Global Kidney Transplant Market Size was worth around USD 8.64 Billion in 2024 and is predicted to Grow to around USD 18.70 Billion by 2035 with a compound annual growth rate (CAGR) of 7.27% from 2025 to 2035. The global kidney transplant market is supported by improved reimbursement policies and insurance coverage, encouraging patients to opt for transplants over dialysis. Additionally, rising investments in transplant infrastructure and skilled workforce development are increasing procedure volumes worldwide.

Market Overview

The global kidney transplant market refers to the ecosystem of surgical procedures, preservation solutions, immunosuppressive therapies, and healthcare services that enable the process of replacing a failed kidney with a healthy donor organ. The market experiences growth because chronic kidney disease and end-stage renal disease become more common, and people learn about organ donation and transplant techniques, plus post-operative care improvements lead to higher survival rates, The growth of the healthcare industry, together with improved access to specialized transplant centers, drives expansion. The national organ donation registries and awareness campaigns, plus policies that assist donor-recipient matching in government programs, have resulted in higher transplant volumes across multiple countries. In November 2024, the Increasing Organ Transplant Access (IOTA) Model rule was finalized by the Centers for Medicare & Medicaid Services (CMS) to increase access to kidney transplants by modifying payment incentives for transplant hospitals. The final rule was published, and implementation begins in July 2025, running through June 2031.

Public and private organizations work together through funding programs to make transplant procedures more affordable and accessible to patients. In July 2025, the Chief Minister Organ Transplant Scheme (CMOTS) in Arunachal Pradesh was expanded to provide Rs.10 lakh for kidney transplants, improving access to affordable transplant procedures and supporting the growth of the kidney transplant market.

The market offers new business opportunities because of advancements in organ preservation technology and the creation of new immunosuppressive drugs that have reduced side effects, and the increasing use of artificial intelligence technology for donor matching and transplant monitoring, which will improve patient outcomes and create new market opportunities.

Report Coverage

This research report categorizes the global kidney transplant market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global kidney transplant market. Recent market developments and competitive strategies, such as expansion, product launch, development, partnership, merger, and acquisition, have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyzes their core competencies in each sub-segment of the kidney transplant market.

Driving Factors  

The global kidney transplant industry experiences growth because more people develop chronic kidney disease and end-stage renal disease, which results from the rising diabetes and hypertension rates among aging populations. The public campaigns and educational programs about organ donation have created greater awareness, which results in increased donor registrations. Medical technology progress in surgical methods, organ preservation, and immunosuppressive treatment development has created better transplant outcomes and longer patient life spans. The growth of healthcare facilities in developing countries, together with better access to specialized transplant centers, enables more patients to receive kidney transplants, which drives market expansion.

Restraining Factors

The global kidney transplant market faces restraints due to the limited availability of donor organs, leading to long waiting lists and delayed procedures. High transplant costs and post-surgical expenses, including lifelong immunosuppressive therapy, also restrict adoption. Additionally, risks of organ rejection, complications, and strict regulatory frameworks further challenge overall market growth.

Market Segmentation

The global kidney transplant market share is classified into donor type, type of transplant, and end user.

• The living donor segment accounted for the largest share in 2024, approximately 60%, and is anticipated to grow at a significant CAGR during the forecast period.           

Based on the donor type, the global kidney transplant market is divided into living donor and deceased donor. Among these, the living donor segment accounted for the largest share in 2024, approximately 60%, and is anticipated to grow at a significant CAGR during the forecast period. This is because kidney transplants from living donors provide superior tissue compatibility, reduce waiting periods for recipients, and achieve higher long-term success and survival rates than deceased-donor transplants, making them the preferred choice for both patients and healthcare providers.

• The non-preemptive kidney transplants segment accounted for the highest market revenue in 2024, approximately 65%, and is anticipated to grow at a significant CAGR during the forecast period.

Based on the type of transplant, the global kidney transplant market is divided into preemptive kidney transplant, non-preemptive kidney transplant, combined kidney-pancreas transplant, re-transplantation, and others. Among these, the non-preemptive kidney transplants segment accounted for the highest market revenue in 2024, approximately 65%, and is anticipated to grow at a significant CAGR during the forecast period. This is because non-preemptive transplants are performed after patients have undergone dialysis, representing the majority of transplant cases, and benefit from established clinical protocols, widespread availability, and higher patient acceptance compared to other transplant types.

• The hospitals segment dominated the market in 2024, approximately 70%, and is projected to grow at a substantial CAGR during the forecast period.

Based on the end user, the global kidney transplant market is divided into hospitals, public/teaching hospitals, private transplant centers, transplant clinics, and dialysis centers. Among these, the hospitals segment dominated the market in 2024, approximately 70%, and is projected to grow at a substantial CAGR during the forecast period. The market dominance is due to hospitals offering comprehensive transplant services, including pre- and post-operative care, advanced surgical facilities, and access to experienced medical professionals, making them the preferred choice for kidney transplant procedures worldwide.

Regional Segment Analysis of the Global Kidney Transplant Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global kidney transplant market over the predicted timeframe.

North America is anticipated to hold the largest share of the global Kidney Transplant market over the predicted timeframe, approximately 45% market share. This growth is driven by North America’s advanced healthcare infrastructure, high number of kidney transplant procedures, strong insurance and reimbursement systems, availability of skilled medical professionals, widespread awareness of organ donation, and well-established transplant centers across the region.

The Asia Pacific region is expected to grow at the fastest rate during the forecast period, capturing approximately 21% market share. This is driven by rising healthcare investments, increasing prevalence of chronic kidney disease, expansion of transplant facilities, growing public awareness of organ donation, improvements in medical infrastructure, government initiatives supporting transplants, and enhanced access to advanced kidney treatments.

Competitive Analysis:    

The report offers the appropriate analysis of the key organizations/companies involved within the global kidney transplant market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• TransMedics Group Inc
• XVIVO Perfusion AB
• OrganOx Limited
• Paragonix Technologies
• Bridge to Life Ltd
• Organ Recovery Systems
• Waters Medical Systems
• Novartis AG
• Astellas Pharma Inc
• Pfizer Inc
• F. Hoffmann-La Roche Ltd
• Sanofi S.A.
• Veloxis Pharmaceuticals Inc
• BioLife Solutions Inc
• Teva Pharmaceutical Industries Ltd
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Development

• In November 2025, Johns Hopkins Medicine developed a new Al-powered tool that predicts kidney transplant graft failure up to three years after surgery using routine lab data, helping clinicians identify high-risk patients for timely intervention.

• In August 2025, Terumo announced its acquisition of OrganOx for approximately USD 1.5 billion, marking a strategic entry into the organ transplantation market. OrganOx specializes in Normothermic Machine Perfusion (NMP), enabling organs to be preserved longer outside the body and improving transplant outcomes.

• In January 2025, Massachusetts General Hospital successfully performed its second xenotransplant of a gene-edited pig kidney into a living human recipient, highlighting progress toward expanding organ supply for transplantation.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the global kidney transplant market based on the below-mentioned segments:      

Global Kidney Transplant Market, By Donor Type

• Living Donor
• Deceased Donor

Global Kidney Transplant Market, By Type of Transplant

• Preemptive Kidney Transplant
• Non-Preemptive Kidney Transplant
• Combined Kidney-Pancreas Transplant
• Re-transplantation
• Others

Global Kidney Transplant Market, By End User

• Hospitals
• Public/Teaching Hospitals
• Private Transplant Centers
• Transplant Clinics
• Dialysis Centers

Global Kidney Transplant Market, By Regional Analysis

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa